Andréanne Michaud1, Marie Michèle Boulet1, Alain Veilleux2, Suzanne Noël3, Gaétan Paris3, André Tchernof4. 1. Endocrinology and Nephrology, Laval University Medical Center; Department of Nutrition, Laval University. 2. Department of Nutrition, University of Montreal, Research Center, CHU Sainte-Justine. 3. Gynecology Unit, Laval University Medical Center Quebec City. 4. Endocrinology and Nephrology, Laval University Medical Center; Department of Nutrition, Laval University. Electronic address: andre.tchernof@crchul.ulaval.ca.
Abstract
OBJECTIVE: We tested the hypothesis that women with adipocyte hypertrophy in either omental (OM) or subcutaneous (SC) adipose tissue are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation, independent of overall adiposity and fat distribution. METHODS: OM and SC fat samples were obtained surgically in 44 women (age: 47.1±5.0years, BMI: 27.7±5.3kg/m(2)). In a given depot, women with larger adipocytes than predicted by the regression of adipocyte size vs. total and regional adiposity measurements were considered as having adipocyte hypertrophy, whereas women with smaller adipocytes than predicted were considered as having adipocyte hyperplasia. RESULTS: Women with OM adipocyte hypertrophy had significantly lower SC GLUT4 mRNA abundance (p≤0.05), higher SC CEBPB mRNA expression (p≤0.05) as well as higher mRNA expression of OM PLIN (p≤0.05), CD68 (p≤0.10), CD14 (p≤0.10), CD31 (p≤0.05) and vWF (p≤0.05) compared to women with OM adipocyte hyperplasia. OM adipocyte isoproterenol- (10(-10) to 10(-5)mol/L), forskolin- (10(-5)mol/L) and dibutyryl cAMP- (10(-3)mol/L) stimulated lipolysis was higher in women with hypertrophic OM adipocytes (p≤0.05, for all). Women with SC adipocyte hypertrophy had lower SC mRNA expression of GLUT4 (p≤0.10), higher SC mRNA expression of CEBPB (p≤0.05), lower plasma adiponectin concentrations (p≤0.05) and higher SC adipocyte isoproterenol- (10(-9) to 10(-5)mol/L) stimulated lipolysis (p≤0.05) compared to women with SC adipocyte hyperplasia. CONCLUSION: Hypertrophic adipocytes in both fat compartments are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation.
OBJECTIVE: We tested the hypothesis that women with adipocyte hypertrophy in either omental (OM) or subcutaneous (SC) adipose tissue are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation, independent of overall adiposity and fat distribution. METHODS: OM and SC fat samples were obtained surgically in 44 women (age: 47.1±5.0years, BMI: 27.7±5.3kg/m(2)). In a given depot, women with larger adipocytes than predicted by the regression of adipocyte size vs. total and regional adiposity measurements were considered as having adipocyte hypertrophy, whereas women with smaller adipocytes than predicted were considered as having adipocyte hyperplasia. RESULTS:Women with OM adipocyte hypertrophy had significantly lower SC GLUT4 mRNA abundance (p≤0.05), higher SC CEBPB mRNA expression (p≤0.05) as well as higher mRNA expression of OM PLIN (p≤0.05), CD68 (p≤0.10), CD14 (p≤0.10), CD31 (p≤0.05) and vWF (p≤0.05) compared to women with OM adipocyte hyperplasia. OM adipocyte isoproterenol- (10(-10) to 10(-5)mol/L), forskolin- (10(-5)mol/L) and dibutyryl cAMP- (10(-3)mol/L) stimulated lipolysis was higher in women with hypertrophic OM adipocytes (p≤0.05, for all). Women with SC adipocyte hypertrophy had lower SC mRNA expression of GLUT4 (p≤0.10), higher SC mRNA expression of CEBPB (p≤0.05), lower plasma adiponectin concentrations (p≤0.05) and higher SC adipocyte isoproterenol- (10(-9) to 10(-5)mol/L) stimulated lipolysis (p≤0.05) compared to women with SC adipocyte hyperplasia. CONCLUSION:Hypertrophic adipocytes in both fat compartments are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation.
Authors: X Liu; J Y Huh; H Gong; J P Chamberland; M T Brinkoetter; O-P R Hamnvik; C S Mantzoros Journal: Int J Obes (Lond) Date: 2015-05-21 Impact factor: 5.095
Authors: Kevin P Cohoon; Matylda Mazur; Robert D McBane; Siva Ketha; Naser Ammash; Waldemar E Wysokinski Journal: Int J Cardiol Date: 2014-12-03 Impact factor: 4.164
Authors: Xiaowen Liu; Nikolaos Perakakis; Huizhi Gong; John P Chamberland; Mary T Brinkoetter; Ole-Petter R Hamnvik; Christos S Mantzoros Journal: Metabolism Date: 2016-09-22 Impact factor: 8.694
Authors: Joseph Frankl; Paolo Piaggi; James E Foley; Jonathan Krakoff; Susanne B Votruba Journal: Obesity (Silver Spring) Date: 2016-11-21 Impact factor: 5.002
Authors: Ezequiel Lozano Chiappe; Maximiliano Martin; Andrea Iglesias Molli; Andrea Millan; Walter Tetzlaff; Eliana Botta; Florencia Ferraro; Maria S Sáez; Maria V Lorenzon Gonzalez; Laura Boero; Patricia Sorroche; Axel Beskow; Mercedes Gutierrez; Gloria Cerrone; Susana Gutt; Gustavo Frechtel; Fernando Brites Journal: Obes Surg Date: 2020-10-30 Impact factor: 4.129